People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn’s disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.
vWD Market Growth Driven by the Increasing Use of Recombinant vWF – Pharmaceutical Technology
The pricing of recombinant vWF therapy and (the coagulation factor VIIII + vWF (human), the blood-clotting protein pictured above) complex will likely hinder access to
August 15, 2023